Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions

Overview

Journal Curr Atheroscler Rep

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2016 Jan 22

PMID 26792015

Citations 68

Authors

J Adam Leigh

Manrique Alvarez

Carlos J Rodriguez

Affiliations

Soon will be listed here.

Abstract

Heart disease remains the leading cause of death in the USA. Overall, heart disease accounts for about 1 in 4 deaths with coronary heart disease (CHD) being responsible for over 370,000 deaths per year. It has frequently and repeatedly been shown that some minority groups in the USA have higher rates of traditional CHD risk factors, different rates of treatment with revascularization procedures, and excess morbidity and mortality from CHD when compared to the non-Hispanic white population. Numerous investigations have been made into the causes of these disparities. This review aims to highlight the recent literature which examines CHD in ethnic minorities and future directions in research and care.

Citing Articles

Bisphenol A and Its Emergent Substitutes: State of the Art of the Impact of These Plasticizers on Oxidative Stress and Its Role in Vascular Dysfunction.

Palacios-Valladares J, Martinez-Jimenez Y, Morillon-Torres V, Rivera-Maya O, Gomez R, Calderon-Aranda E Antioxidants (Basel). 2025; 13(12.

PMID: 39765797 PMC: 11673293. DOI: 10.3390/antiox13121468.

Simplifying coronary artery disease risk stratification: development and validation of a questionnaire-based alternative comparable to clinical risk tools.

Kokkorakis M, Folkertsma P, Anagnostakis F, Sirotin N, Agarwal M, Shantouf R EBioMedicine. 2024; 111:105518.

PMID: 39724785 PMC: 11732493. DOI: 10.1016/j.ebiom.2024.105518.

Costs and Healthcare Utilization of Heart Disease by COVID-19 Diagnosis and Race and Ethnicity.

Lee J, Zhang Y, Pollack L, Luo F AJPM Focus. 2024; 4(1):100285.

PMID: 39628935 PMC: 11613426. DOI: 10.1016/j.focus.2024.100285.

Ethnic disparities and lifestyle determinants in the prevalence of cardiovascular disease among Han majority and Ha Ni ethnic minority older adults in rural Southwest China.

Huang Y, Li Q, Zuo M, Liu L, Li G, Cai L BMC Cardiovasc Disord. 2024; 24(1):653.

PMID: 39548385 PMC: 11568549. DOI: 10.1186/s12872-024-04327-7.

Differential prediction performance between Caribbean- and Mainland-subgroups using state-of-the-art polygenic risk scores for coronary heart disease: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Hutten C, Boehm F, Smith J, Spitzer B, Wassertheil-Smoller S, Isasi C medRxiv. 2024; .

PMID: 39399039 PMC: 11469406. DOI: 10.1101/2024.09.25.24313663.

References

Mensah G, Mokdad A, Ford E, Greenlund K, Croft J . State of disparities in cardiovascular health in the United States. Circulation. 2005; 111(10):1233-41. DOI: 10.1161/01.CIR.0000158136.76824.04. View

DeVon H, Burke L, Nelson H, Zerwic J, Riley B . Disparities in patients presenting to the emergency department with potential acute coronary syndrome: it matters if you are Black or White. Heart Lung. 2014; 43(4):270-7. PMC: 4082800. DOI: 10.1016/j.hrtlng.2014.04.019. View

Gillespie C, Wigington C, Hong Y . Coronary heart disease and stroke deaths - United States, 2009. MMWR Suppl. 2013; 62(3):157-60. View

Pollock B, Hamman B, Sass D, da Graca B, Grayburn P, Filardo G . Effect of gender and race on operative mortality after isolated coronary artery bypass grafting. Am J Cardiol. 2015; 115(5):614-8. DOI: 10.1016/j.amjcard.2014.12.010. View

Kang H, Clare R, Gao R, Held C, Himmelmann A, James S . Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Am Heart J. 2015; 169(6):899-905.e1. DOI: 10.1016/j.ahj.2015.03.015. View

Becker E, Rahimi A . Disparities in race/ethnicity and gender in in-hospital mortality rates for coronary artery bypass surgery patients. J Natl Med Assoc. 2006; 98(11):1729-39. PMC: 2569791. View

Waksman R, Maya J, Angiolillo D, Carlson G, Teng R, Caplan R . Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot Study. Circ Cardiovasc Interv. 2015; 8(7):e002232. DOI: 10.1161/CIRCINTERVENTIONS.114.002232. View

Dong C, Rundek T, Wright C, Anwar Z, Elkind M, Sacco R . Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation. 2012; 125(24):2975-84. PMC: 3396556. DOI: 10.1161/CIRCULATIONAHA.111.081083. View

Curtis J, Herrin J, Bratzler D, Bradley E, Krumholz H . Trends in race-based differences in door-to-balloon times. Arch Intern Med. 2010; 170(11):992-3. DOI: 10.1001/archinternmed.2010.165. View

10.

Movahed M, Khan M, Hashemzadeh M, Hashemzadeh M . Age adjusted nationwide trends in the incidence of all cause and ST elevation myocardial infarction associated cardiogenic shock based on gender and race in the United States. Cardiovasc Revasc Med. 2014; 16(1):2-5. DOI: 10.1016/j.carrev.2014.07.007. View

11.

Burke J, Vijan S, Chekan L, Makowiec T, Thomas L, Morgenstern L . Targeting high-risk employees may reduce cardiovascular racial disparities. Am J Manag Care. 2014; 20(9):725-33. View

12.

Kurian A, Cardarelli K . Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007; 17(1):143-52. View

13.

. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989; 129(4):687-702. View

14.

Sempos C, Bild D, Manolio T . Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American men and women. Am J Med Sci. 1999; 317(3):142-6. DOI: 10.1097/00000441-199903000-00002. View

15.

Tourdot B, Conaway S, Niisuke K, Edelstein L, Bray P, Holinstat M . Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis. Arterioscler Thromb Vasc Biol. 2014; 34(12):2644-50. PMC: 4239175. DOI: 10.1161/ATVBAHA.114.304249. View

16.

Dauerman H, Bates E, Kontos M, Li S, Garvey J, Henry T . Nationwide Analysis of Patients With ST-Segment-Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2015; 8(5). DOI: 10.1161/CIRCINTERVENTIONS.114.002450. View

17.

Medina-Inojosa J, Jean N, Cortes-Bergoderi M, Lopez-Jimenez F . The Hispanic paradox in cardiovascular disease and total mortality. Prog Cardiovasc Dis. 2014; 57(3):286-92. DOI: 10.1016/j.pcad.2014.09.001. View

18.

Mathews R, Wang T, Honeycutt E, Henry T, Zettler M, Chang M . Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. Am Heart J. 2015; 170(1):62-9. PMC: 4808054. DOI: 10.1016/j.ahj.2015.03.019. View

19.

McKee M, Winters P, Fiscella K . Low education as a risk factor for undiagnosed angina. J Am Board Fam Med. 2012; 25(4):416-21. PMC: 3607287. DOI: 10.3122/jabfm.2012.04.110282. View

20.

Cortes-Bergoderi M, Goel K, Murad M, Allison T, Somers V, Erwin P . Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox. Eur J Intern Med. 2013; 24(8):791-9. DOI: 10.1016/j.ejim.2013.09.003. View